A detailed history of China Universal Asset Management Co., Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,172 shares of INVA stock, worth $199,133. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,172
Previous 12,172 -0.0%
Holding current value
$199,133
Previous $186,000 0.54%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$14.56 - $16.78 $69,334 - $79,906
4,762 Added 64.26%
12,172 $186,000
Q4 2023

May 21, 2024

SELL
$12.32 - $16.27 $58,667 - $77,477
-4,762 Reduced 39.12%
7,410 $118,000
Q4 2023

Jan 23, 2024

BUY
$12.32 - $16.27 $70,667 - $93,324
5,736 Added 342.65%
7,410 $119,000
Q3 2023

May 21, 2024

BUY
$12.37 - $13.89 $10,093 - $11,334
816 Added 95.1%
1,674 $21,000
Q3 2023

Oct 30, 2023

BUY
$12.37 - $13.89 $10,093 - $11,334
816 Added 95.1%
1,674 $22,000
Q2 2023

May 21, 2024

SELL
$11.39 - $13.72 $740 - $891
-65 Reduced 7.04%
858 $10,000
Q2 2023

Jul 27, 2023

SELL
$11.39 - $13.72 $740 - $891
-65 Reduced 7.04%
858 $11,000
Q1 2023

May 21, 2024

BUY
$10.73 - $13.6 $2,296 - $2,910
214 Added 30.18%
923 $10,000
Q1 2023

Apr 27, 2023

BUY
$10.73 - $13.6 $2,296 - $2,910
214 Added 30.18%
923 $10,000
Q4 2022

May 21, 2024

SELL
$11.8 - $13.78 $135,263 - $157,960
-11,463 Reduced 94.18%
709 $9,000
Q4 2022

Jan 31, 2023

BUY
$11.8 - $13.78 $660 - $771
56 Added 8.58%
709 $9,000
Q3 2022

Oct 21, 2022

BUY
$11.61 - $15.22 $7,581 - $9,938
653 New
653 $8,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.14B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.